<DOC>
	<DOCNO>NCT01814111</DOCNO>
	<brief_summary>The purpose study demonstrate whether renal sympathetic denervation safe effective patient hypertension paroxysmal atrial fibrillation .</brief_summary>
	<brief_title>Renal Sympathetic Denervation Patients With Hypertension Paroxysmal Atrial Fibrillation</brief_title>
	<detailed_description>Atrial fibrillation ( AF ) one common cardiac arrhythmia , complication AF stroke , thromboembolism heart failure bring high disable rate mortality , serious influence people 's health aggrandize medical financial burden , however , treatment AF ideal . The affection traditional antiarrhythmia drug enough good , due extra-heart bad reaction potential arrhythmogenic substrate function restrict ; rate control strategy apply quite abroad , however , anticoagulated medicine apply enough , Radiofrequency catheter ablation AF develop rapidly recent year , But 's station also dispute success rate low recrudescence high . meanwhile , serious complication cause . So far , hypertension risk factor AF . Long-term hypertension change left-ventricle structure , variability pressure load capacity loading , damage diastolic function left-ventricle . Increase diastolic pressure left-ventricle atrial pressure gradually result atrial enlargement fibrosis , cause atrial fibrillation , repeat paroxysm slow maintaining . Investigation indicate anti-hypertension therapy decrease occurrence ratio reoccurrence ratio AF . Recently , many clinical research verify renal sympathetic denervation acquire exact sustain hypotension effect , In addition , Renal sympathetic denervation reduce leave ventricular hypertrophy , improve glucose metabolization obstructive sleep , meanwhile , reduce level nonepinephrine partial whole-body . While left ventricle hypertrophy , leave atrium enlarge，epinephrine release breath sleep obstacle independent dangerous factor emerge AF . So , design randomize parallel control multi center clinical study demonstrate renal sympathetic denervation safe effective treatment patient hypertension paroxysmal atrial fibrillation .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>1 . Individual ≥ 18 ≤ 75 year age . 2 . More half year definite hypertension . 3 . AF common superventricular arrhythmia characterize chaotic contraction atrium . An electrocardiogram ( EGG ) record necessary diagnose AF . At least 30 second rhythm strip EGG record least 1 AF outbreak record EGG Holter half year . 4 . Paroxysmal AF Individual , Paroxysmal AF define recurrent AF ( ≧2 episodes ) terminate spontaneously within 7 day . Episodes AF ≤ 48 hour ' duration terminate electrical pharmacologic cardioversion also classify paroxysmal AF episode . 5 . Individual eligible condition renal artery CTA inspection , undoubled renal artery one side , renal artery length≧2cm , diameter≧4mm , distortion incept sect . 6 . Agree attend clinic experiment sign write informed consent . 1 . Persistent AF Individual , Persistent AF define continuous AF sustain beyond seven day . Episodes AF decision make electrically pharmacologically cardiovert patient _≧48 hour AF , prior 7 day , also classify persistent AF episode . 2 . Individual Severely enlarge leave atria≥ 55 mm 3 . Individual reversibility mostly generate AF , abnormal hypothyroid structural heart diseases 4 . Individual experience renal artery stenosis ，or A history prior renal artery intervention include balloon angioplasty stenting . ineligible condition renal artery CTA inspection , double renal artery one side , renal artery length≤2cm , diameter≤4mm , distortion incept sect . 5 . Individual experience definite acute coronary syndrome recent 3 month , cerebrovascular accident alimentary canal bleeding within 3 month 6 . Individual experience sick sinus syndrome 7 . Pregnant Women planning Pregnant Women , psychopathy Individual , individual sensitive visualization , individual cooperate followup visit , individual researcher think unsuitable include study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Arrhythmias , Cardiac</keyword>
	<keyword>Heart Diseases</keyword>
	<keyword>Cardiovascular Diseases</keyword>
</DOC>